Time: Three Hours Maximum: 100 Marks
I. Elaborate on: (2 x 15 = 30)
--- Content provided by FirstRanker.com ---
1. Discuss the recent changes in the WHO 2016 criteria for diagnosis of
myeloproliferative neoplasms.
2. Discuss the diagnosis and relevance of Philadelphia like acute
--- Content provided by FirstRanker.com ---
lymphoblastic leukemia. Also discuss potential strategies to treat theseconditions.
II. Write notes on: (10 x 7 = 70)
--- Content provided by FirstRanker.com ---
1. Anti-Leukemia Activity of the Selective BCL-2 Inhibitor ABT-199.2. Role of hypo-methylating agents in high risk young adults with acute
myeloid leukemia.
3. Thrombopoeitin receptor agonists and aplastic anemia.
4. Liposomal CPX-351 in acute myeloid leukemia.
--- Content provided by FirstRanker.com ---
5. Targeting microenvironment in leukemia.6. Artesunate in the management of cytomegalovirus infection.
7. Gene editing strategies.
8. Potential role of Pioglitazone in the management of chronic myeloid
leukemia.
--- Content provided by FirstRanker.com ---
9. Potential role and rationale of IL2 in management of acute graft versushost disease.
10. Nontransplant therapy in aplastic anemia.
--- Content provided by FirstRanker.com ---
*******www.FirstRanker.com www.FirstRanker.com
www.FirstRanker.com
FirstRanker.com - FirstRanker's Choice
--- Content provided by FirstRanker.com ---